|
|
protein activation cascade
|
GO:0072376 |
19 |
0.895
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.818
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.757
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.720
|
|
|
|
activation of membrane attack complex
|
GO:0001905 |
4 |
0.703
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.614
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.557
|
|
|
|
positive regulation of protein kinase c activity
|
GO:1900020 |
1 |
0.544
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.539
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.464
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.430
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.410
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.397
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.390
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.387
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.385
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.358
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.352
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.347
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.341
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.328
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.323
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.306
|
Human |
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.303
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.289
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.282
|
|
|
|
regulation of complement activation
|
GO:0030449 |
7 |
0.267
|
|
|
|
positive regulation of protein activation cascade
|
GO:2000259 |
2 |
0.264
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.258
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.246
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.240
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.231
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.224
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.217
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.216
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.213
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.198
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.197
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.189
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.186
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.184
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.183
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.177
|
|
|
|
regulation of protein activation cascade
|
GO:2000257 |
7 |
0.177
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.172
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.168
|
|
|
|
negative regulation of coagulation
|
GO:0050819 |
11 |
0.161
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.161
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.161
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.157
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.156
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.153
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.151
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.142
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.138
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.137
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.135
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.134
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.134
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.134
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.134
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.129
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.128
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.127
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.126
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.124
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.123
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.123
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.121
|
|
|
|
regulation of macrophage activation
|
GO:0043030 |
17 |
0.119
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.118
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.116
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.116
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.116
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.115
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.115
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.110
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.108
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.106
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.105
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.103
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.103
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.103
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.102
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.100
|
|
|
|
regulation of immunoglobulin mediated immune response
|
GO:0002889 |
37 |
0.098
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.098
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.098
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.098
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.094
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.094
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.093
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.093
|
|
|
|
regulation of humoral immune response
|
GO:0002920 |
22 |
0.091
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.090
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.090
|
|
|
|
negative regulation of hemostasis
|
GO:1900047 |
11 |
0.089
|
|
|
|
regulation of b cell mediated immunity
|
GO:0002712 |
37 |
0.088
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.087
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.087
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.086
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.086
|
|
|
|
astrocyte activation
|
GO:0048143 |
2 |
0.085
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.085
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.085
|
|
|
|
complement activation lectin pathway
|
GO:0001867 |
5 |
0.084
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.084
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.083
|
|
|
|
positive regulation of protein maturation
|
GO:1903319 |
7 |
0.082
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.082
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.081
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.081
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.080
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.080
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.080
|
|
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.079
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.079
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.078
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.078
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.077
|
|
|
|
regulation of protein kinase c activity
|
GO:1900019 |
1 |
0.075
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.074
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.073
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.073
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.071
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.070
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.070
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.069
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.069
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.068
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.067
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.067
|
|
|
|
negative regulation of blood coagulation
|
GO:0030195 |
11 |
0.067
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.066
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.066
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.065
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.064
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.064
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.063
|
|
|
|
positive regulation of complement activation
|
GO:0045917 |
2 |
0.063
|
|
|
|
positive regulation of cholesterol storage
|
GO:0010886 |
3 |
0.063
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.062
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.060
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.060
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.060
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.059
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.058
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.058
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.057
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.057
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.057
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.056
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.056
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.054
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.054
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.053
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.053
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.053
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.052
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.052
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.051
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.051
|
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.051
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.051
|
|
|
|
ovarian follicle rupture
|
GO:0001543 |
2 |
0.051
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.051
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.050
|
|
|
|
positive regulation of b cell mediated immunity
|
GO:0002714 |
26 |
0.050
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.050
|
Human |
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.050
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.050
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.050
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.049
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.049
|
|
|
|
positive regulation of myeloid leukocyte mediated immunity
|
GO:0002888 |
14 |
0.048
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.048
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.048
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.047
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.047
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.047
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.046
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.046
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.045
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.045
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.045
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.045
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.045
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.045
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.044
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.043
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.043
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.043
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.043
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.043
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.042
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.042
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.042
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.042
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.042
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.041
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.041
|
|
|
|
positive regulation of macrophage derived foam cell differentiation
|
GO:0010744 |
4 |
0.041
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.041
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.041
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.040
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.040
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.040
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.039
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.039
|
|
|
|
negative regulation of carbohydrate metabolic process
|
GO:0045912 |
19 |
0.039
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.039
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.039
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.038
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.038
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.038
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.038
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.037
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.037
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.037
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.036
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.036
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.036
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.036
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.036
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.036
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.036
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.035
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.035
|
|
|
|
phasic smooth muscle contraction
|
GO:0014821 |
8 |
0.035
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014068 |
20 |
0.035
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.035
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.035
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.035
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.035
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.035
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.035
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.034
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.034
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.034
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.034
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.034
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.033
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.033
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.033
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.033
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.033
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.033
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.033
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.032
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.032
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.032
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.032
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.032
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.032
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.031
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.031
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.031
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.031
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.031
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.031
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.031
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.031
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.031
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.031
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.031
|
|
|
|
protein n linked glycosylation
|
GO:0006487 |
12 |
0.031
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.031
|
|
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.031
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.031
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.030
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.030
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.030
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.030
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.030
|
|
|
|
regulation of toll like receptor 4 signaling pathway
|
GO:0034143 |
4 |
0.030
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.030
|
|
|
|
negative regulation of wound healing
|
GO:0061045 |
14 |
0.030
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.029
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.029
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.029
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.029
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.029
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.029
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.029
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.029
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.029
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.028
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.028
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.028
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.028
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.028
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.028
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.028
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.028
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.027
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.027
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.027
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.027
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.027
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.027
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.027
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.027
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.027
|
|
|
|
positive regulation of type ii hypersensitivity
|
GO:0002894 |
4 |
0.027
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.027
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.026
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.026
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.026
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.026
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.026
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.026
|
|
|
|
neurological system process involved in regulation of systemic arterial blood pressure
|
GO:0001976 |
18 |
0.026
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.026
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.026
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.026
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.026
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.025
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.025
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.025
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.025
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.025
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.025
|
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.025
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.025
|
|
|
|
renal response to blood flow involved in circulatory renin angiotensin regulation of systemic arterial blood pressure
|
GO:0001999 |
6 |
0.025
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.025
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.025
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.024
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.024
|
|
|
|
positive regulation of tissue remodeling
|
GO:0034105 |
19 |
0.024
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.024
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.024
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.024
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.024
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.024
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.024
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.024
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.024
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.023
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.023
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.023
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.023
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.023
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.023
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.023
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.023
|
|
|
|
innate immune response in mucosa
|
GO:0002227 |
3 |
0.023
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.023
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.023
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.023
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.023
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.023
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.023
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.022
|
|
|
|
glucocorticoid metabolic process
|
GO:0008211 |
9 |
0.022
|
|
|
|
brain renin angiotensin system
|
GO:0002035 |
5 |
0.022
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.022
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.022
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.022
|
|
|
|
plasma lipoprotein particle clearance
|
GO:0034381 |
13 |
0.022
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.022
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.022
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.022
|
|
|
|
positive regulation of organ growth
|
GO:0046622 |
29 |
0.022
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.022
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.022
|
|
|
|
interaction with symbiont
|
GO:0051702 |
14 |
0.021
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.021
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.021
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.021
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.021
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.021
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.021
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.021
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.021
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.021
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.021
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.021
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.021
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.021
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.021
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.020
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.020
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.020
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.020
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.020
|
|
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
18 |
0.020
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.020
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.020
|
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.020
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.020
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.020
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.020
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.020
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.020
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.020
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.020
|
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.020
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.020
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.020
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.020
|
|
|
|
negative regulation of lipoprotein lipase activity
|
GO:0051005 |
1 |
0.019
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.019
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.019
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.019
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.019
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.019
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.019
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.019
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.019
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.019
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.019
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.019
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.019
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.019
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.019
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.019
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.019
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.018
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.018
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.018
|
|
|
|
positive regulation of protein processing
|
GO:0010954 |
7 |
0.018
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.018
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.018
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.018
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.018
|
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.018
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.018
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.018
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.018
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.018
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.018
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.018
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.017
|
|
|
|
hepatocyte growth factor receptor signaling pathway
|
GO:0048012 |
3 |
0.017
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.017
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.017
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.017
|
|
|
|
acute inflammatory response to antigenic stimulus
|
GO:0002438 |
12 |
0.017
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.017
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.017
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.017
|
|
|
|
positive regulation of immunoglobulin mediated immune response
|
GO:0002891 |
26 |
0.017
|
|
|
|
inflammatory response to antigenic stimulus
|
GO:0002437 |
30 |
0.017
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.017
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.017
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.017
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.017
|
|
|
|
regulation of blood vessel size by renin angiotensin
|
GO:0002034 |
5 |
0.017
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.017
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.017
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.017
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.017
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.017
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.017
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.017
|
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.017
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.017
|
|
|
|
regulation of endothelial cell apoptotic process
|
GO:2000351 |
9 |
0.017
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.017
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.017
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.017
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.017
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.017
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.017
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.017
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.016
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.016
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.016
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.016
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.016
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.016
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.016
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.016
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.016
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.016
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.016
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.016
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.016
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.016
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.016
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.016
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.016
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.016
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.016
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.016
|
|